Not registered yet? Get a free account.

Sign Up
search icon cancel icon

MARKSANS PHARMA LIMITED

www.marksanspharma.com
Active
Updated: 04 Jul 2025

The company is engaged in manufacturing of pharmaceutical products such as phenolphthalein, caffeine and abatacept injection etc.

Marksans Pharma Limited, is an unlisted public company incorporated on 16 April, 1992. It is classified as a public limited company and is located in , . It's authorized share capital is INR 69.00 cr and the total paid-up capital is INR 45.32 cr.

Read more

Subscription Plans
Industry and products
Manufacturing (Chemicals and chemical products)
  • Gincoplex Pharmaceutical Medicine, Carfin Suspension, Injection, Caffeine, Potassium Caprylate, Apresoline, Phenolphthalein, Abatacept Injection, Haematinic Syrup
Company size
Auth Capital
₹ 69.0 Cr
Paidup Capital
₹ 45.3 Cr
Revenue
₹ 750-1000 cr
Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Total Revenue
27.9%
₹ GET PRO
EBITDA
52.26%
₹ GET PRO
Net Profit
30.03%
₹ GET PRO
Networth
10.02%
₹ GET PRO
Borrowings
-
₹ GET PRO
Assets
12.73%
₹ GET PRO
Gross Margin
4.07
GET PRO %
Operating Margin
2.37
GET PRO %
Net Profit Margin
0.24
GET PRO %
Return on Equity
1.68
GET PRO %
ROCE
2.81
GET PRO %
Debt to Equity
-
GET PRO
Sales
Mar 2024
Net worth
Mar 2024

Locations

indian flag India (6)
State Type Address

location icon Locations on Map

Map placeholder

People

Designation Name DIN/PAN Tenure
Whole-time Director Sandra Saldanha
Shareholder
00021023 11 years
Director Varddhman Vikramaditya Jain 08338573 6 years
Director Abhinna Mohanty Sundar 00007995 6 years
Managing Director Mark Saldanha
Shareholder
00020983 10 years
Director Digant Mahesh Parikh 00212589 7 years
Director Sunny Sharma 02267273 4 years
Director Shailaja Vardhan 10172764 2 years

Financial Highlights

Financials upto March 2024 available in Tofler Pro
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales GET PRO GET PRO GET PRO GET PRO GET PRO
Operating profit GET PRO GET PRO GET PRO GET PRO GET PRO
Net profit GET PRO GET PRO GET PRO GET PRO GET PRO
Gross margin GET PRO GET PRO GET PRO GET PRO GET PRO
Operating margin GET PRO GET PRO GET PRO GET PRO GET PRO
Net margin GET PRO GET PRO GET PRO GET PRO GET PRO
Networth
Borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Debt to equity GET PRO GET PRO GET PRO GET PRO GET PRO
Current ratio GET PRO GET PRO GET PRO GET PRO GET PRO
ROE GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
WC days GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Margins

Gross margin
Operating margin
Net margin

Balance Sheet

Standalone
Consolidated
%

Financials upto March 2024 available in Tofler Pro

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital GET PRO GET PRO GET PRO GET PRO GET PRO
Reserves GET PRO GET PRO GET PRO GET PRO GET PRO
Borrowings + GET PRO GET PRO GET PRO GET PRO GET PRO
Long term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Short term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Trade payables + GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
Other liabilities + GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Other current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Total liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Fixed Assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Tangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
CWIP GET PRO GET PRO GET PRO GET PRO GET PRO
Intangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
LT loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Current assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Inventories GET PRO GET PRO GET PRO GET PRO GET PRO
Trade receivables GET PRO GET PRO GET PRO GET PRO GET PRO
Cash and cash equivalents GET PRO GET PRO GET PRO GET PRO GET PRO
ST loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Total assets GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Total assets

Charges on assets

Bank wise
Charges
1

State Bank of India

No. of Loans: 1

Total Amount : 226.0 cr

chart icon

Charges

State Bank of India

Company Network

Companies connected through Directors

Name Status Paid up Capital Common Directors Address
RYTUS THERAPEUTICS LIMITED
Active
6.2 Cr 1 Maharashtra
RYTUS HEALTHCARE FOUNDATION
Active
75,000.0 1 Maharashtra
SSB SEVA KARTAVYA FOUNDATION
Active
1.0 L 1 Maharashtra
MARISE LABORATORIES PRIVATE LIMITED
Strike Off
1.0 L 2 Maharashtra
SCHENELLE PROPERTY HOLDINGS PRIVATE LIMI TED
Strike Off
1.0 L 2 Maharashtra
MERRILL LABORATORIES PRIVATE LIMTIED
Strike Off
1.0 L 2 Maharashtra
AKANSHA CONSULTANCY SERVICES LIMITED
Active
90.0 L 1 Gujarat
PARIKH SHARES AND STOCKS PVT LTD
Strike Off
31.0 L 1 Gujarat
PRATHAMESH EDU-INFRA PRIVATE LIMITED
Strike Off
3.3 L 1 Maharashtra
PARIKH SECURITIES PVT LTD
Strike Off
5.0 L 1 Gujarat
ROSSELL TECHSYS LIMITED
Active
7.5 Cr 1 West Bengal
ROSSELL TECHSYS LIMITED
Active
7.5 Cr 1
KIMS HEALTH CARE AND RESEARCH CENTER LIM ITED
Amalgamated
11.8 Cr 1 Kerala
ORBIMED ADVISORS INDIA PRIVATE LIMITED
Active
2.0 Cr 1 Maharashtra
INNOVATION IMAGING TECHNOLOGIES PRIVATE LIMITED
Active
11.6 Cr 1 Karnataka
ARCATRON MOBILITY PRIVATE LIMITED
Active
66.7 L 1 Maharashtra
ADRET RETAIL PRIVATE LIMITED
Active
20.4 Cr 1 West Bengal
SHASUN PHARMACEUTICALS LIMITED
Amalgamated
13.5 Cr 1
ADVANCED ENZYME TECHNOLOGIES LIMITED
Active
22.4 Cr 1
LIFECELL INTERNATIONAL PRIVATE LIMITED
Active
16.7 Cr 1
INNVOLUTION HEALTHCARE PRIVATE LIMITED
Active
16.3 L 1

Subsidiary Companies

Name State / Country Incorporation Year Paidup Capital
Marksans Pharma (UK) Limited United Kingdom - -
Nova Pharmaceuticals Australasia Pty Ltd Australia - -
Marksans Pharma Inc United States - -
Access Healthcare For Medical Products LLC United Arab Emirates - -

Tofler Score

score img
Poor
Fair
Good
Very Good
Excellent

Risk

Severe Risk
  • No risks identified
Moderate Risk
  • No risks identified
Low Risk
  • No risks identified
About Tofler Score
Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Read more

Registered Details

CIN

L24110MH1992PLC066364

PAN

AAACT3153G

Incorporation

1992, 33.2 years

Company Email

harshavardhan@marksanspharma.com

Paid up Capital

₹ 45.3 Cr

Authorised Capital

₹ 69.0 Cr

AGM

Sep 2024

Type

Public
Others

FAQ - MARKSANS PHARMA LIMITED

What is the incorporation date of MARKSANS PHARMA LIMITED?

plus icon

The incorporation date of MARKSANS PHARMA LIMITED is 16 April, 1992

What is the authorized share capital of MARKSANS PHARMA LIMITED?

plus icon

The authorized share capital of MARKSANS PHARMA LIMITED is INR ₹ 69.0 Cr.

What is the paid-up capital of MARKSANS PHARMA LIMITED?

plus icon

The paid-up capital of MARKSANS PHARMA LIMITED is INR ₹ 45.3 Cr.

What is the registered address of MARKSANS PHARMA LIMITED?

plus icon

The registered address of MARKSANS PHARMA LIMITED is 11th Floor, GRANDEUR, Veera Desai Extension Road Oshiwara, Andheri (W), Mumbai City, Mumbai, Maharashtra, India, 400053 - 400053

What is the CIN number of MARKSANS PHARMA LIMITED?

plus icon

The CIN number of MARKSANS PHARMA LIMITED is L24110MH1992PLC066364.

Smart Suggestions

  • Uttar Pradesh
  • Haryana
  • Jammu & Kashmir
  • Punjab
  • Goa
  • Madhya Pradesh
  • Kerala
  • Gujarat
  • Andhra Pradesh
  • Telangana
  • Blog Categories
  • Top Blog post
  • Financial Resources
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More